| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.86e-07 | 9 | 126 | 4 | GO:0045134 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 7.19e-07 | 12 | 126 | 4 | GO:0004382 | |
| GeneOntologyMolecularFunction | CTPase activity | 4.84e-06 | 6 | 126 | 3 | GO:0043273 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 6.77e-06 | 20 | 126 | 4 | GO:0017110 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCB7 NTPCR DNAH2 KIF12 ATP9B CPOX KIF24 ABCC6 ATAD3C SLC27A1 ENTPD2 KIF28P DDX60L | 1.37e-04 | 614 | 126 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 2.35e-04 | 4 | 126 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ENTPD7 ABCB7 NTPCR DUT DNAH2 KIF12 ATP9B ENTPD4 ABCC6 ATAD3C ENTPD2 ENTPD3 KIF28P RAB7A DDX60L | 2.65e-04 | 839 | 126 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ENTPD7 ABCB7 NTPCR DUT DNAH2 KIF12 ATP9B ENTPD4 ABCC6 ATAD3C ENTPD2 ENTPD3 KIF28P RAB7A DDX60L | 2.68e-04 | 840 | 126 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ENTPD7 ABCB7 NTPCR DUT DNAH2 KIF12 ATP9B ENTPD4 ABCC6 ATAD3C ENTPD2 ENTPD3 KIF28P RAB7A DDX60L | 2.68e-04 | 840 | 126 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ENTPD7 ABCB7 NTPCR DNAH2 KIF12 ATP9B ENTPD4 ABCC6 ATAD3C ENTPD2 ENTPD3 KIF28P RAB7A DDX60L | 3.87e-04 | 775 | 126 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCB7 NTPCR DNAH2 KIF12 ATP9B ABCC6 ATAD3C ENTPD2 KIF28P DDX60L | 4.92e-04 | 441 | 126 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 8.13e-04 | 7 | 126 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.00e-03 | 70 | 126 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | kinase activity | RFK GAK GRK5 GRK6 NME9 ERN2 PTK2B MTOR NIM1K ALDH18A1 PRKG1 MUSK EPHA1 | 1.09e-03 | 764 | 126 | 13 | GO:0016301 |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate metabolic process | 1.52e-05 | 25 | 126 | 4 | GO:0009147 | |
| Domain | GDA1_CD39_NTPase | 1.31e-07 | 8 | 125 | 4 | IPR000407 | |
| Domain | GDA1_CD39 | 1.31e-07 | 8 | 125 | 4 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 1.31e-07 | 8 | 125 | 4 | PS01238 | |
| Domain | Tox-GHH_dom | 2.64e-04 | 4 | 125 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.64e-04 | 4 | 125 | 2 | PF15636 | |
| Domain | Ten_N | 2.64e-04 | 4 | 125 | 2 | IPR009471 | |
| Domain | Ten_N | 2.64e-04 | 4 | 125 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.64e-04 | 4 | 125 | 2 | PS51361 | |
| Domain | Quinoprotein_ADH-like_supfam | 4.34e-04 | 53 | 125 | 4 | IPR011047 | |
| Domain | YD | 4.39e-04 | 5 | 125 | 2 | IPR006530 | |
| Domain | Gal_Oxase/kelch_b-propeller | 6.55e-04 | 59 | 125 | 4 | IPR011043 | |
| Domain | GPCR_kinase | 9.13e-04 | 7 | 125 | 2 | IPR000239 | |
| Domain | Kelch_1 | 1.25e-03 | 70 | 125 | 4 | PF01344 | |
| Domain | Kelch_1 | 1.25e-03 | 70 | 125 | 4 | IPR006652 | |
| Domain | DHR-1_domain | 2.35e-03 | 11 | 125 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.35e-03 | 11 | 125 | 2 | PS51651 | |
| Domain | DHR_1 | 2.35e-03 | 11 | 125 | 2 | PS51650 | |
| Domain | DHR-2 | 2.35e-03 | 11 | 125 | 2 | PF06920 | |
| Domain | DOCK | 2.35e-03 | 11 | 125 | 2 | IPR026791 | |
| Domain | GAIN_dom_N | 2.35e-03 | 11 | 125 | 2 | IPR032471 | |
| Domain | DOCK_C | 2.35e-03 | 11 | 125 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.35e-03 | 11 | 125 | 2 | PF14429 | |
| Domain | DHR-2 | 2.35e-03 | 11 | 125 | 2 | IPR027357 | |
| Domain | GAIN | 2.35e-03 | 11 | 125 | 2 | PF16489 | |
| Domain | AAA | 2.84e-03 | 144 | 125 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.84e-03 | 144 | 125 | 5 | IPR003593 | |
| Domain | Kelch_2 | 3.30e-03 | 13 | 125 | 2 | IPR011498 | |
| Domain | Kelch_2 | 3.30e-03 | 13 | 125 | 2 | PF07646 | |
| Domain | NHL | 3.30e-03 | 13 | 125 | 2 | PS51125 | |
| Domain | Kinase-like_dom | 3.51e-03 | 542 | 125 | 10 | IPR011009 | |
| Domain | ConA-like_dom | 3.58e-03 | 219 | 125 | 6 | IPR013320 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.60e-03 | 46 | 125 | 3 | IPR011042 | |
| Domain | PROTEIN_KINASE_ATP | 3.75e-03 | 459 | 125 | 9 | PS00107 | |
| Domain | BTB | 4.46e-03 | 160 | 125 | 5 | PS50097 | |
| Domain | Prot_kinase_dom | 5.64e-03 | 489 | 125 | 9 | IPR000719 | |
| Domain | CY | 5.66e-03 | 17 | 125 | 2 | SM00043 | |
| Domain | Thioredoxin_CS | 5.66e-03 | 17 | 125 | 2 | IPR017937 | |
| Domain | PROTEIN_KINASE_DOM | 5.94e-03 | 493 | 125 | 9 | PS50011 | |
| Domain | AGC-kinase_C | 6.27e-03 | 56 | 125 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.27e-03 | 56 | 125 | 3 | PS51285 | |
| Domain | S_TK_X | 6.27e-03 | 56 | 125 | 3 | SM00133 | |
| Domain | Cystatin_dom | 6.34e-03 | 18 | 125 | 2 | IPR000010 | |
| Domain | Cystatin | 6.34e-03 | 18 | 125 | 2 | PF00031 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.27e-07 | 8 | 94 | 4 | M27737 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.27e-07 | 8 | 94 | 4 | MM15486 | |
| Pathway | REACTOME_NUCLEOTIDE_CATABOLISM | 8.29e-05 | 35 | 94 | 4 | MM15550 | |
| Pathway | REACTOME_NUCLEOTIDE_CATABOLISM | 8.29e-05 | 35 | 94 | 4 | M27829 | |
| Pubmed | GAK DCAF8 HLA-A PMPCB MSI1 TSNAX MTOR AGL RAB7A LZTS2 MTO1 SIPA1L2 | 3.13e-06 | 606 | 130 | 12 | 36538041 | |
| Pubmed | 6.01e-06 | 10 | 130 | 3 | 38713721 | ||
| Pubmed | CNTN4 NAALAD2 ABCB7 DSP ADAM23 GRK5 AOC2 KANK2 ENTPD4 FUBP1 SLC27A1 TENM1 TRA2A LZTS2 SIPA1L2 EPHA1 | 1.29e-05 | 1215 | 130 | 16 | 15146197 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 26901106 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25387269 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17786238 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28472257 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20038610 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | SLC25A46 ENOSF1 RFK ABCB7 PMPCB NTPCR DUT BCKDHB CPOX NARS2 GLDC DNAJC15 ALDH18A1 SLC25A44 MTO1 | 2.38e-05 | 1136 | 130 | 15 | 34800366 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FNDC3B GAK ABCB7 HLA-A DSP DUT CPOX ADAM10 NARS2 PPP4C ATAD3C CELSR2 CSPG4 CST2 TMX4 RAB7A ALDH18A1 | 3.03e-05 | 1451 | 130 | 17 | 30550785 |
| Pubmed | GAK ABCB7 WDR36 DCAF8 HLA-A HECTD3 PMPCB BCKDHB KANK2 WDR6 DNAJC15 TMX4 RAB7A LRRC61 LZTS2 SIPA1L2 ADGRL2 | 4.11e-05 | 1487 | 130 | 17 | 33957083 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 7789183 | ||
| Pubmed | G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway. | 4.15e-05 | 3 | 130 | 2 | 19801552 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 30551391 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 34417976 | ||
| Pubmed | Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate. | 4.15e-05 | 3 | 130 | 2 | 20805505 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 18662895 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 21807070 | ||
| Pubmed | Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. | 4.15e-05 | 3 | 130 | 2 | 12032308 | |
| Pubmed | Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium. | 4.15e-05 | 3 | 130 | 2 | 10467231 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 28699640 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 26924460 | ||
| Pubmed | 4.82e-05 | 172 | 130 | 6 | 27375898 | ||
| Pubmed | CNTN4 ETF1 GRM2 KANK2 AGO3 CELSR2 MTOR DOCK7 RAB7A PPP1R3F GIGYF2 FBXO45 CDH11 | 6.87e-05 | 963 | 130 | 13 | 28671696 | |
| Pubmed | Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. | 8.28e-05 | 4 | 130 | 2 | 18404504 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 37709195 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 8.28e-05 | 4 | 130 | 2 | 10225957 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 29969579 | ||
| Pubmed | Cloning and mapping of a human and mouse gene with homology to ecto-ATPase genes. | 8.28e-05 | 4 | 130 | 2 | 9271669 | |
| Pubmed | Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. | 8.28e-05 | 4 | 130 | 2 | 17727821 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 9676430 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 21784156 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 11504827 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 33291075 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 8.28e-05 | 4 | 130 | 2 | 12000766 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RBM15 WDR36 HLA-A PMPCB DSP ETF1 DUT CPOX MTOR WDR6 FUBP1 DOCK7 RAB7A ALDH18A1 TRA2A GIGYF2 | 8.68e-05 | 1425 | 130 | 16 | 30948266 |
| Pubmed | 9.87e-05 | 122 | 130 | 5 | 30773093 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 12507501 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 27232975 | ||
| Pubmed | 1.54e-04 | 304 | 130 | 7 | 32235678 | ||
| Pubmed | 1.54e-04 | 407 | 130 | 8 | 12693553 | ||
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | SLC25A46 RFK PMPCB DUT BCKDHB CPOX NARS2 ATAD3C GLDC DNAJC15 ALDH18A1 SLC25A44 MTO1 | 1.57e-04 | 1047 | 130 | 13 | 18614015 |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | SLC25A46 RFK PMPCB DUT BCKDHB CPOX NARS2 GLDC DNAJC15 ALDH18A1 SLC25A44 MTO1 | 1.93e-04 | 926 | 130 | 12 | 20877624 |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 9826657 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 9211925 | ||
| Pubmed | beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. | 2.06e-04 | 6 | 130 | 2 | 20530803 | |
| Pubmed | Characterization of dUTPase expression in mouse postnatal development and adult neurogenesis. | 2.06e-04 | 6 | 130 | 2 | 38849394 | |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 10506199 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 17060617 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 29627294 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 22696681 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 36451830 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 20352108 | ||
| Pubmed | Host cell targets of tegument protein VP22 of herpes simplex virus 1. | 2.88e-04 | 7 | 130 | 2 | 21424732 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 8672451 | ||
| Pubmed | Mapping a chromosomal locus for valproic acid-induced exencephaly in mice. | 2.88e-04 | 7 | 130 | 2 | 15170225 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 12915301 | ||
| Pubmed | Lysosomal dynamics regulate mammalian cortical neurogenesis. | 2.88e-04 | 7 | 130 | 2 | 38103552 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 11517230 | ||
| Pubmed | DCAF8 HECTD3 NTPCR BCKDHB MSI1 KANK2 AGO3 WDR6 CHPF2 LZTS2 MTO1 SIPA1L2 ADGRL2 | 2.92e-04 | 1116 | 130 | 13 | 31753913 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GAK DCAF8 PMPCB CPOX KANK2 MTOR WDR6 AGL RAB7A LZTS2 SIPA1L2 ADGRL2 | 3.05e-04 | 974 | 130 | 12 | 28675297 |
| Pubmed | GAK ABCB7 WDR36 DCAF8 HLA-A DUT ADAM10 PPP4C MTOR WDR6 DOCK7 ALDH18A1 DDX60L ADGRL2 ALPI | 3.27e-04 | 1440 | 130 | 15 | 30833792 | |
| Pubmed | PMPCB DSP GRK5 GRK6 DNAH2 CPOX NARS2 ATAD3C FUBP1 SLC27A1 CSPG4 ENTPD2 TENM1 LSM14A SIPA1L2 | 3.32e-04 | 1442 | 130 | 15 | 35575683 | |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 3.56e-04 | 89 | 130 | 4 | 27034005 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.61e-04 | 462 | 130 | 8 | 31138677 | |
| Pubmed | 3.83e-04 | 8 | 130 | 2 | 10331952 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.87e-04 | 91 | 130 | 4 | 28558017 | |
| Pubmed | 3.91e-04 | 164 | 130 | 5 | 32409323 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RBM15 KLHDC2 DSP FSD1 NARS2 PTK2B MTOR DOCK7 GIGYF2 SIPA1L2 MUSK | 4.04e-04 | 861 | 130 | 11 | 36931259 |
| Pubmed | Genome-wide association study of primary dentition pit-and-fissure and smooth surface caries. | 4.23e-04 | 39 | 130 | 3 | 24556642 | |
| Pubmed | Molecular basis for GIGYF-Me31B complex assembly in 4EHP-mediated translational repression. | 4.91e-04 | 9 | 130 | 2 | 31439631 | |
| Pubmed | Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. | 4.91e-04 | 9 | 130 | 2 | 18180038 | |
| Pubmed | 5.33e-04 | 99 | 130 | 4 | 31723608 | ||
| Pubmed | 5.53e-04 | 376 | 130 | 7 | 24154525 | ||
| Pubmed | Synucleins are a novel class of substrates for G protein-coupled receptor kinases. | 6.12e-04 | 10 | 130 | 2 | 10852916 | |
| Pubmed | RBM15 WDR36 DSP MSI1 TBC1D8B AGO3 WDR6 AGL DOCK7 RAB7A ALDH18A1 TRA2A LSM14A LZTS2 | 6.33e-04 | 1371 | 130 | 14 | 36244648 | |
| Pubmed | CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. | 7.40e-04 | 108 | 130 | 4 | 30166453 | |
| Pubmed | 8.93e-04 | 12 | 130 | 2 | 31289197 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 9.23e-04 | 298 | 130 | 6 | 32353859 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 ENGASE GRK5 GRK6 AOC2 TBC1D25 CELSR2 MTOR CSPG4 ENTPD2 WDR90 SIPA1L2 | 9.25e-04 | 1105 | 130 | 12 | 35748872 |
| Pubmed | 9.32e-04 | 51 | 130 | 3 | 16919471 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 9.36e-04 | 807 | 130 | 10 | 22681889 | |
| Pubmed | GAK DSP ETF1 GRM2 KANK2 PTK2B TENM4 ATAD3C SLC27A1 DOCK7 RAB7A HRG SIPA1L2 ABLIM2 | 9.57e-04 | 1431 | 130 | 14 | 37142655 | |
| Pubmed | 1.05e-03 | 13 | 130 | 2 | 16949250 | ||
| Pubmed | mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. | 1.05e-03 | 13 | 130 | 2 | 25533187 | |
| Pubmed | 1.14e-03 | 686 | 130 | 9 | 29987050 | ||
| Pubmed | 1.16e-03 | 209 | 130 | 5 | 26389662 | ||
| Pubmed | 1.23e-03 | 14 | 130 | 2 | 39245708 | ||
| Pubmed | 1.23e-03 | 14 | 130 | 2 | 12432077 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.23e-03 | 315 | 130 | 6 | 26777405 | |
| Pubmed | 1.34e-03 | 438 | 130 | 7 | 32628020 | ||
| Pubmed | 1.41e-03 | 15 | 130 | 2 | 25338677 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 1.41e-03 | 15 | 130 | 2 | 31285543 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 1.42e-03 | 571 | 130 | 8 | 37167062 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SLC25A46 ABCB7 WDR36 PMPCB NTPCR MSI1 CPOX NARS2 WDR6 FUBP1 TMX4 RAB7A TRA2A MTO1 | 1.46e-03 | 1496 | 130 | 14 | 32877691 |
| Pubmed | GAK HLA-A GRK6 NTPCR ITGAL ADAM10 AGO3 MTOR SLC27A1 GIGYF2 CHPF2 CTSW | 1.48e-03 | 1168 | 130 | 12 | 19946888 | |
| Pubmed | 1.58e-03 | 224 | 130 | 5 | 32941674 | ||
| Pubmed | 1.61e-03 | 16 | 130 | 2 | 28199315 | ||
| Pubmed | 1.61e-03 | 16 | 130 | 2 | 21301993 | ||
| Pubmed | 1.61e-03 | 16 | 130 | 2 | 33253712 | ||
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | DOCK3 ENGASE NAALAD2 ADAM23 GRK5 NTPCR FSD1 MSI1 NARF CELSR2 FIG4 GLDC WDR6 SLC27A1 PGAP1 PPP1R3F ADGRL2 CDH11 | 1.82e-05 | 967 | 127 | 18 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.02e-07 | 162 | 130 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.94e-07 | 170 | 130 | 7 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-06 | 198 | 130 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-06 | 198 | 130 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.84e-06 | 142 | 130 | 6 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.34e-06 | 145 | 130 | 6 | 9743d68ba8bfef56fd9a979ab357c0e287eb5ae2 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.49e-06 | 163 | 130 | 6 | 036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 176 | 130 | 6 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.31e-05 | 176 | 130 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 176 | 130 | 6 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-05 | 179 | 130 | 6 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.56e-05 | 107 | 130 | 5 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.56e-05 | 107 | 130 | 5 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-05 | 185 | 130 | 6 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-05 | 185 | 130 | 6 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-05 | 185 | 130 | 6 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.74e-05 | 185 | 130 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.85e-05 | 187 | 130 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-05 | 188 | 130 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 190 | 130 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.09e-05 | 191 | 130 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.09e-05 | 191 | 130 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 192 | 130 | 6 | 9e031bf93eb8757fdd0cc22f01b44e48f85532d5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 193 | 130 | 6 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 193 | 130 | 6 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-05 | 194 | 130 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.28e-05 | 194 | 130 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.34e-05 | 195 | 130 | 6 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 195 | 130 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 196 | 130 | 6 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.48e-05 | 197 | 130 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.63e-05 | 199 | 130 | 6 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.63e-05 | 199 | 130 | 6 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 2.63e-05 | 199 | 130 | 6 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 200 | 130 | 6 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-05 | 200 | 130 | 6 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.70e-05 | 200 | 130 | 6 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.62e-05 | 134 | 130 | 5 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.88e-05 | 72 | 130 | 4 | af3077e43d4b7abfd99146a71961142f946af136 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.88e-05 | 72 | 130 | 4 | e13ee52d9a795cdc35068b0d8f8e6ed92adf8b66 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.89e-05 | 150 | 130 | 5 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 152 | 130 | 5 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 152 | 130 | 5 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.78e-05 | 157 | 130 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 159 | 130 | 5 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 159 | 130 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 159 | 130 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.10e-04 | 161 | 130 | 5 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 161 | 130 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 1.20e-04 | 164 | 130 | 5 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.27e-04 | 166 | 130 | 5 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 1.38e-04 | 169 | 130 | 5 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.42e-04 | 170 | 130 | 5 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.46e-04 | 171 | 130 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5Rgs5_(Mural.Acta2Rgs5Rgs5)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 91 | 130 | 4 | b576c4ab6ec2f80682dd51dc72dde35f99b1c7eb | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 91 | 130 | 4 | 7a60989eeb495e42e72e6d5d403e8d34027f9bd0 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5Rgs5_(Mural.Acta2Rgs5Rgs5)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 91 | 130 | 4 | 8f072b10386ef2742e7f95dcfbc42bfacf2af5f1 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 173 | 130 | 5 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 173 | 130 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 1.54e-04 | 173 | 130 | 5 | 300904fd35536a69be81d76fe33fe16544523ceb | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 173 | 130 | 5 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 173 | 130 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 173 | 130 | 5 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.58e-04 | 174 | 130 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.58e-04 | 174 | 130 | 5 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 177 | 130 | 5 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 177 | 130 | 5 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.71e-04 | 177 | 130 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 179 | 130 | 5 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 179 | 130 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-04 | 180 | 130 | 5 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 180 | 130 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 180 | 130 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 181 | 130 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-04 | 181 | 130 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 182 | 130 | 5 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 182 | 130 | 5 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 2.00e-04 | 183 | 130 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 183 | 130 | 5 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 184 | 130 | 5 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 184 | 130 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 184 | 130 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-04 | 184 | 130 | 5 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 184 | 130 | 5 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.05e-04 | 184 | 130 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| Disease | smoking status measurement, aggressive periodontitis | 5.50e-05 | 3 | 127 | 2 | EFO_0006342, EFO_0006527 | |
| Disease | taurine measurement | 1.88e-04 | 26 | 127 | 3 | EFO_0010536 | |
| Disease | level of Phosphatidylinositol (18:1_18:2) in blood serum | 2.73e-04 | 6 | 127 | 2 | OBA_2045160 | |
| Disease | 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement | 2.73e-04 | 6 | 127 | 2 | EFO_0800404 | |
| Disease | cholesterol to total lipids in very large HDL percentage | 3.20e-04 | 31 | 127 | 3 | EFO_0022243 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0800609 | |
| Disease | level of Sterol ester (27:1/22:6) in blood serum | 3.81e-04 | 7 | 127 | 2 | OBA_2045201 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 5.06e-04 | 8 | 127 | 2 | EFO_0800610 | |
| Disease | Hereditary Motor and Sensory Neuropathy Type I | 5.06e-04 | 8 | 127 | 2 | C0751036 | |
| Disease | Roussy-Levy Syndrome (disorder) | 5.06e-04 | 8 | 127 | 2 | C0205713 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 5.06e-04 | 8 | 127 | 2 | EFO_0800396 | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 5.06e-04 | 8 | 127 | 2 | OBA_2045153 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ib | 5.06e-04 | 8 | 127 | 2 | C0270912 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 5.06e-04 | 8 | 127 | 2 | C0270911 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0800439 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0800412 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 6.55e-04 | 91 | 127 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 8.09e-04 | 10 | 127 | 2 | EFO_0800469 | |
| Disease | nephritis (implicated_via_orthology) | 8.09e-04 | 10 | 127 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 8.09e-04 | 10 | 127 | 2 | OBA_2045075 | |
| Disease | free cholesterol to total lipids in IDL percentage | 8.47e-04 | 43 | 127 | 3 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 8.47e-04 | 43 | 127 | 3 | EFO_0022254 | |
| Disease | Secondary Open Angle Glaucoma | 1.18e-03 | 12 | 127 | 2 | C0271148 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 1.18e-03 | 12 | 127 | 2 | EFO_0008258 | |
| Disease | granulins measurement | 1.18e-03 | 12 | 127 | 2 | EFO_0008141 | |
| Disease | Charcot-Marie-Tooth Disease | 1.18e-03 | 12 | 127 | 2 | C0007959 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.18e-03 | 12 | 127 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.18e-03 | 12 | 127 | 2 | OBA_2045157 | |
| Disease | Glaucoma, Open-Angle | 1.18e-03 | 12 | 127 | 2 | C0017612 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.24e-03 | 49 | 127 | 3 | EFO_0022256 | |
| Disease | phosphatidylcholine 40:7 measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0021477 | |
| Disease | transmembrane protein 87B measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0802158 | |
| Disease | Glaucoma, Primary Open Angle | 1.39e-03 | 13 | 127 | 2 | C0339573 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 1.39e-03 | 13 | 127 | 2 | OBA_2045159 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0800413 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.39e-03 | 13 | 127 | 2 | C0270914 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.39e-03 | 51 | 127 | 3 | EFO_0022242 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.39e-03 | 51 | 127 | 3 | EFO_0022285 | |
| Disease | R-6-hydroxywarfarin measurement | 1.52e-03 | 114 | 127 | 4 | EFO_0803327 | |
| Disease | asthma | SLC25A46 DOCK3 WDR36 ETF1 CSMD3 GLDC PPP1R3F PRKG1 FBXO45 MUSK | 1.55e-03 | 751 | 127 | 10 | MONDO_0004979 |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 1.62e-03 | 14 | 127 | 2 | EFO_0022085 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.62e-03 | 14 | 127 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.62e-03 | 14 | 127 | 2 | OBA_2045142 | |
| Disease | triglycerides in IDL measurement | 2.02e-03 | 58 | 127 | 3 | EFO_0022149 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 2.02e-03 | 58 | 127 | 3 | EFO_0022338 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 2.12e-03 | 16 | 127 | 2 | EFO_0800184 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 2.12e-03 | 16 | 127 | 2 | OBA_2045090 | |
| Disease | Antihistamine use measurement | 2.40e-03 | 17 | 127 | 2 | EFO_0009943 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | 2.40e-03 | 17 | 127 | 2 | EFO_0008011 | |
| Disease | triglycerides in medium LDL measurement | 2.45e-03 | 62 | 127 | 3 | EFO_0022322 | |
| Disease | free cholesterol in very large HDL measurement | 2.45e-03 | 62 | 127 | 3 | EFO_0022273 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 2.69e-03 | 18 | 127 | 2 | EFO_0010365 | |
| Disease | spine bone size | 2.69e-03 | 18 | 127 | 2 | EFO_0004508 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 2.69e-03 | 18 | 127 | 2 | OBA_2045155 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 2.69e-03 | 18 | 127 | 2 | OBA_2045065 | |
| Disease | cholesterol in very large VLDL measurement | 2.80e-03 | 65 | 127 | 3 | EFO_0022230 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.95e-03 | 225 | 127 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 3.00e-03 | 19 | 127 | 2 | OBA_2045140 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.00e-03 | 19 | 127 | 2 | EFO_0802076 | |
| Disease | total lipids in large VLDL | 3.05e-03 | 67 | 127 | 3 | EFO_0022175 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.18e-03 | 68 | 127 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | free cholesterol in large VLDL measurement | 3.18e-03 | 68 | 127 | 3 | EFO_0022265 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 3.32e-03 | 20 | 127 | 2 | OBA_2045071 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 3.66e-03 | 21 | 127 | 2 | OBA_2045156 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 3.66e-03 | 21 | 127 | 2 | EFO_0010762 | |
| Disease | e-selectin measurement | 4.01e-03 | 22 | 127 | 2 | EFO_0004575 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEGEFGEVYRGTLRL | 631 | P21709 | |
| ETRRRAVIYFHGGGF | 101 | Q6P093 | |
| SILEYRDFLQRGGGA | 476 | O75077 | |
| LYGIREGDGFSNRDV | 671 | Q7Z407 | |
| FQAGGRRGDFIYVDI | 241 | Q6UVK1 | |
| DGRFEGFIQTRGGTF | 121 | O14672 | |
| AVDRRVFIAGLGLYG | 416 | Q96KE9 | |
| LIEFGGNIYARDNRG | 201 | Q8WXK3 | |
| VRFDRFGDGIGRYNI | 441 | Q14416 | |
| ELQNGRGFGYVVAFR | 726 | Q8IWV2 | |
| RVDGTGFVVYDGAVF | 206 | O95490 | |
| DLAEGGFFVRQGEYI | 56 | Q6H8Q1 | |
| LNGRVFYTFQGGDDG | 846 | Q9HCU4 | |
| IFYRDGVSEGQFRQV | 666 | Q9H9G7 | |
| QAGEVAFRRTGYLRG | 11 | Q8TBR5 | |
| FGVVGNRSRFAKGDY | 51 | O75071 | |
| FRGAQIISGQEEGVY | 171 | O75355 | |
| IIVRGFGFQIGVRYE | 951 | Q96T37 | |
| GQERFQSLGVAFYRG | 66 | P51149 | |
| GVFSGLRIFDVRFQG | 336 | O75106 | |
| AVIFGEDVAFGGVFR | 91 | P21953 | |
| VRGLYEGEGFAAFQG | 91 | P0C881 | |
| RNEYIGEFVNGYRHG | 281 | P0C881 | |
| VRGLYEGEGFAAFQG | 91 | B2RC85 | |
| RNEYIGEFVNGYRHG | 281 | B2RC85 | |
| RLEDGYFRIGKFENG | 481 | Q9UM21 | |
| LIRGAAGRSLYFGEN | 26 | O75439 | |
| YGAGAGDLEFVRRTV | 4321 | Q99102 | |
| YGQREFTAGFVQFRV | 226 | Q8WWA0 | |
| VFNGLVYAAGGRNAE | 416 | Q9H511 | |
| ERVARVRGGEGTGYF | 181 | P04196 | |
| FRQQDGLLRGGYEAQ | 56 | Q9BRK4 | |
| TFLGFGGNFARQRYE | 311 | Q9NQZ7 | |
| DGERVIGRGSEFYQL | 161 | Q9BV99 | |
| RDQGGFREVRNEYGS | 256 | Q96AE4 | |
| FREVRNEYGSRIGGN | 261 | Q96AE4 | |
| RLFFAGQINGTTGYE | 426 | Q9Y2Z2 | |
| VGVAYRSLGRFEQLG | 371 | Q9BTV5 | |
| RGFYVEQLRVVEFGS | 186 | Q96FN5 | |
| EYIIRQGARGDTFFI | 246 | Q13976 | |
| FLNEYFGIGRVSFGA | 1086 | O43861 | |
| GGTFVFRGQFEGRAV | 531 | Q76MJ5 | |
| GDVFIRQFYSVFDRG | 371 | P14091 | |
| GRRGQDLLGNVYFFD | 1311 | Q5H9U9 | |
| GDFRGFYRQLTSDGQ | 86 | Q7L5Y1 | |
| RGYGFDERAFGGVIF | 411 | Q9Y5L3 | |
| SYFSQFREERGGGFL | 31 | Q96I76 | |
| QFAVGGRDQFVRIYD | 346 | Q5TAQ9 | |
| FTAFVYRGLRGDDAI | 251 | P25021 | |
| FIYRQERGGGSSFDL | 946 | Q5T7B8 | |
| FRGGRGGREFADFEY | 441 | Q8ND56 | |
| FYTEEVRQGGRRIGF | 36 | Q9BSD7 | |
| GGQIFVDRDGDLFSF | 46 | Q8N5I3 | |
| EDYRGNVGVVLFNFG | 191 | P33316 | |
| IGFYRIRGEIGSGNF | 71 | Q8IY84 | |
| TTQEGLREYFGQFGE | 31 | O43347 | |
| NVFGDGLVRLDGQLY | 71 | Q5VYS4 | |
| RFSDGYRFGLGAEVG | 726 | P54886 | |
| NPRGFYLFVEGGRID | 321 | P09923 | |
| EFVFLGFASVGYVRG | 11 | Q8NGY6 | |
| RVRRVLAEGGFAFVY | 41 | O14976 | |
| AVNGGIARYQEAFFD | 1551 | Q8IZD9 | |
| RLEGFYGERFGEDVV | 1876 | Q96N67 | |
| YQRSFDEVEGVFGRG | 136 | Q6Y7W6 | |
| GGAVFGGQVARVYEF | 261 | Q8N5D6 | |
| LAFERGYEFLGVAFR | 241 | P0C2W1 | |
| GVAALAFAGRYAFRI | 46 | Q9Y5T4 | |
| SAFGVVGFVRFLEGY | 91 | Q92562 | |
| GTVYRFRVRALNDGG | 736 | Q53EP0 | |
| LGRLLVFYVRENGEG | 556 | Q8IZJ3 | |
| EAGQRFLEFQYLTGG | 2721 | P15924 | |
| EEEFGQLYGYRRAAG | 96 | P56202 | |
| NRDNTAGVYARRGGF | 546 | P55287 | |
| RAAGTLFGEGFRAFV | 51 | Q5T2N8 | |
| DVGSDGRFLRGYRQD | 126 | P04439 | |
| RRSLQFVGVNGGYES | 496 | Q63ZY3 | |
| VGNRGFVFGGRYRDA | 226 | Q9Y2U9 | |
| ARLQGFDGELRGYAV | 66 | Q5VU92 | |
| VFARGNVVGGRFDTD | 331 | Q8NFI3 | |
| LRAREQIVGGVNYFF | 71 | P09228 | |
| VLNRILGEGFFGEVY | 426 | Q14289 | |
| FRQYRVLGKGGFGEV | 186 | P34947 | |
| FRQYRVLGKGGFGEV | 186 | P43250 | |
| YNFFLRGGVVLDREG | 3706 | Q9P225 | |
| FRGVEEVYRTARFGQ | 436 | Q6ZMJ2 | |
| DYFFIAHRGERRGIG | 321 | P36551 | |
| GGLRIREDQQLGFYV | 176 | B7ZC32 | |
| VEGGNATRIGRFANY | 96 | P42345 | |
| FSDGAYRIRGRDGGF | 416 | O14926 | |
| GFTSGRRYFEVDVGE | 341 | O00635 | |
| IIGGSRYVAGIEGFF | 401 | Q68CR1 | |
| NFGISYLGRDRLGQE | 81 | Q3MII6 | |
| QGGQIEFRDFGLRYR | 1261 | O95255 | |
| AGIRAYEQLGQRAFG | 106 | Q8WUX1 | |
| ELFGGGLREERYHFL | 401 | Q96I59 | |
| LGFGGNAARQRYEDR | 326 | Q9Y227 | |
| YFRNETGGEGDRRIA | 411 | Q9P2F8 | |
| NTSDGVGYFRGVERV | 276 | Q9BXF9 | |
| GSVYVGDFNFVRRIF | 1206 | Q9UKZ4 | |
| AGGFRDYQVRSGLTF | 241 | Q75T13 | |
| RADGITGLYRGFLVN | 66 | Q96H78 | |
| GGRVFIYQRRQLGFE | 491 | P20701 | |
| YGVSRAGAAFFNEVR | 196 | O75027 | |
| FESRNGDYAREGGRF | 246 | O75969 | |
| YLGRAEEFIGAGEQA | 206 | Q9P2E5 | |
| LCGRRYRFEGEGDIQ | 96 | Q86TL0 | |
| DGIFRRYRGPGIFED | 116 | Q9H1E5 | |
| FELYGADFVLGRDFR | 521 | A6PVC2 | |
| QRLAAGYGDGSLRIF | 1496 | Q96KV7 | |
| RLQVRTAGYVGFGFS | 51 | Q6UVY6 | |
| FVLQRRRGYGEEGGG | 26 | Q0IIM8 | |
| IRQEEGVFGFYKGFG | 376 | Q96AG3 | |
| ERFGVRQIGEFYGAT | 376 | Q6PCB7 | |
| FDGRLYAIGGEFQRT | 256 | C9JR72 | |
| VYDQRTGRSRGFAFV | 151 | Q13595 | |
| LRQRGGDIFEYNSAG | 2261 | Q6N022 | |
| TGRVQGYDGFFVISV | 2731 | Q6N022 | |
| EGAGDGARLDFVVRY | 251 | Q6ZSY5 | |
| GRGRAAYTFNIEAVG | 6 | O15318 | |
| YFCRGQVVRGFGRGS | 6 | Q969G6 | |
| LFYAGGELVAVVRGA | 86 | Q86XW9 | |
| GRDGAYYQLFVRDGQ | 586 | Q9NNW5 | |
| LRQVYDGFSFIGNTG | 221 | Q99598 | |
| QVRGRDFGDLLIYSG | 61 | C9JI98 | |
| RGAGYLFGSDVVAQF | 211 | P60510 | |
| AADGRLVFAAYGNVF | 131 | Q8NI36 | |
| FGGIGGILRYRVDFQ | 406 | P62495 | |
| LFRGARGYVGHEFIL | 851 | P23378 | |
| VDEETGFVYGGNRFN | 1241 | P35573 | |
| GAGIVVGYGDRSRFI | 686 | Q5T447 | |
| LNGFVFILGGAYARA | 776 | Q96CT2 | |
| FEAYFQRLGIASGRA | 511 | Q9Y3Q0 | |
| NGEVVLRFAAAYGFR | 336 | Q9UHQ1 | |
| EYVRDIGEGAFGRVF | 576 | O15146 |